PKM and neoplasm: Consistent with in vitro experiment, intratumoral injection of si-PKM2 modified by cholesterol significantly restrained the growth of subcutaneous xenografts accelerated by circCYP24A1, including tumor volume and weight (Fig. 7a-d).